Aletaha, Daniel <br/><br/>
Disease activity early in the course of treatment predicts response to therapy after one year in rheumatoid arthritis patients.  [electronic resource] 

 -  Arthritis and rheumatism  Oct 2007 
 - 3226-35 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0004-3591 
<br/><br/><label>Standard No.: </label>10.1002/art.22943  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Antirheumatic Agents--therapeutic use<br/>Arthritis, Rheumatoid--drug therapy<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Infliximab<br/>Male<br/>Methotrexate--therapeutic use<br/>Middle Aged<br/>Randomized Controlled Trials as Topic<br/>Severity of Illness Index<br/>Time Factors<br/>Treatment Outcome